Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Otegbeye, Folashade  [Clear All Filters]
2024
Woost PG, William BM, Cooper BW, Oshima MUeda, Otegbeye F, De Lima MJ, Wald D, Mahfouz RZ, Saunthararajah Y, Stefan T, et al. Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies. Cytometry B Clin Cytom. 2024.
2023
Wang J, Sanati F, Firoozmand A, Fu P, Kolk M, Reese-Koc J, de Lima M, Boughan K, Cooper B, Caimi P, et al. Phase I study of intra-osseous co-transplantation of a single-unit cord blood and mesenchymal stromal cells with reduced intensity conditioning regimens. Front Oncol. 2023;13:1186532.
2022
Ali N, Sharma AArunkumar, de Rezende ACarolina P, Otegbeye F, Latif BMuhammad, Kerbauy MNassif, Cooper BW, Sanchez G, Metheny L, Bal SK, et al. Targeted Marrow Irradiation Intensification of Reduced Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation. Transplant Cell Ther. 2022.
2020
Dharmavaram G, Cao S, Sundaram S, Ayyapan S, Boughan K, Gallogly M, Malek E, Metheny L, Tomlinson B, Otegbeye F, et al. Aggressive Lymphoma Subtype Is A Risk Factor for Venous Thrombosis. Development of Lymphoma - Specific Venous Thrombosis Prediction Models. Am J Hematol. 2020.
Smith JNP, Otegbeye F, Jogasuria AP, Christo KF, Gerson SL, Markowitz S, Desai AB. Inhibition of 15-PGDH Protects Mice from Immune-mediated Bone Marrow Failure. Biol Blood Marrow Transplant. 2020.
2019
Jurdi NEl, Filali-Mouhim A, Salem I, Retuerto M, Dambrosio NMargaret, Baer L, Lazarus HM, Caimi P, Cooper B, Tomlinson B, et al. Gastrointestinal Microbiome and Mycobiome changes during Autologous Transplantation for Multiple Myeloma: Results of a Prospective Pilot Study. Biol Blood Marrow Transplant. 2019.